HealZen Therapeutics
- Biotech or pharma, therapeutic R&D
**We will not be meeting with CMOs, CROs, or other vendors at this conference**
HealZen is a clinical-stage biopharmaceutical company committed to the discovery and development of innovative, differentiated small molecule drugs.
- Small-molecule (including TPD, target protein degradation) focused biotech
- Balanced pipeline with both late stage assets (ph 3 trials ongoing) and early stage (lead/PCC to IND) programs
- Potential FIC or BIC Protac/molecular glue asstes targeting to tumor and immunology ready for out-licensing
- Open for platform collaboration including Protac/Molecular glue/DAC(Degrader antibody conjugate)/CNS penetraable compound
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}